CN1112834A - Oral liquid for curing hepatitis B, and method for prodn. of same - Google Patents

Oral liquid for curing hepatitis B, and method for prodn. of same Download PDF

Info

Publication number
CN1112834A
CN1112834A CN 94109284 CN94109284A CN1112834A CN 1112834 A CN1112834 A CN 1112834A CN 94109284 CN94109284 CN 94109284 CN 94109284 A CN94109284 A CN 94109284A CN 1112834 A CN1112834 A CN 1112834A
Authority
CN
China
Prior art keywords
radix
fructus
juice
hepatitis
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 94109284
Other languages
Chinese (zh)
Inventor
郭约翰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 94109284 priority Critical patent/CN1112834A/en
Publication of CN1112834A publication Critical patent/CN1112834A/en
Pending legal-status Critical Current

Links

Abstract

The oral liquid is preod. from root of bupleurum, rhizome of nutgrass flatsedge, curcuma root, root of Chinese angelica and other 24 ingredients of Chinese herbal medicines, it is indicated for treatment of hepatitis B, and features short course of treatment, quick efficacy, safety and no side-effect.

Description

Oral liquid for curing hepatitis B, and method for prodn. of same
The present invention relates to a kind of manufacture method of controlling the hepatitis B medicine and products thereof.
There are the various hepatitis B medicines of controlling to sell at present on the market, certain therapeutic effect is arranged, but all there is not late result, can not effect a radical cure hepatitis B, so that the hepatitis B disease is still wildness and stretches uncontrollable, many hepatitis B patients lose normal viability because of obstinate, even are developed to the serious disastrous effect of " sclerosis " " canceration ".Though the hepatitis B patient who has can obtain " false ", the misfortune that be unable to escape recurrence eventually, cancerates, this just gives the human human body and brings great infringement mentally.
The object of the present invention is to provide and a kind ofly can fundamentally cure hepatitis B, treatment cycle is short, and instant effect is safe and reliable, Bao oral liquid of the hepatitis B that has no side effect and preparation method thereof.
The technical solution of the present invention i.e. manufacture method of the Bao oral liquid of this hepatitis B is as follows:
A, with 2~4% CAIHU, 3~5% radix curcumaes, 4~6% Radix Angelicae Sinensis, 4~6% Radix Paeoniae Albas, 4~6% Rhizoma Atractylodis Macrocephalaes, 4~6% Poria, the 4th~6% full buildings, 4~6% Bulbus Allii Macrostemonis, 5~7% Fructus Lyciis, 3~5% Radix Glycyrrhizaes, 1~3% Herba Menthae, 4~7% Fructus Gardeniae, 4~6% Herba Artemisiae Scopariaes, 4~6% Radix Isatidiss, 4~6% Radix Scutellariaes, 5~7% Radix Sophorae Flavescentiss, 5~7% Radix Rehmanniae, 2~4% Fructus Aurantiis, 4~6% Fructus Crataegis, 2~4% Semen Raphanis (the above-mentioned unit of weight that is) mix homogeneously, make main body according to a conventional method and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
It is that obtaining concentration is 45~55%(weight/volume in 95% the ethanol that c, the Radix Notoginseng with 50~60%, 25~35% Dan Xiang, 1~3% SHANGMEIQI, 0.5~1.5% Oleum menthae, 8~12% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration) the reinforcement solution that looses;
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, with 92~95%(volume) main body decoct juice, 1~2%(volume) broken flavor fourth liquid, 2~4%(volume) reinforcement loose solution and 2~4%(volume) Herba Pogostemonis decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
The Bao oral liquid of hepatitis B of the present invention can be made concentrated oral liquid as required, or is mixed with the dilution oral liquid with distilled water, and the oral liquid of 500 milliliters of not diluted can divide and take in 3~7 days.Patient can take 30~90 days continuously according to the weight of the state of an illness; General patient can cure a course of treatment, and more serious 2~3 courses of treatment of need treatment, 3 months is a course of treatment.
The Bao oral liquid of hepatitis B of the present invention can fundamentally be cured hepatitis B, and clinical effective rate is 100%, and cure rate and state of an illness negative conversion rate are more than 90%, no longer recurrence after healing, lifetime immunity and cross immunity.The treatment cycle of this oral liquid is short, and instant effect is safe and reliable, has no side effect.
Below in conjunction with embodiment and clinical example the present invention is described in more detail.
Embodiment 1:
The Bao oral liquid of this hepatitis B is made by following method:
A, with 3% CAIHU, 4.5% Rhizoma Cyperi, 3.8% radix curcumae, 5.2% Radix Angelicae Sinensis, 5% Radix Paeoniae Alba, 4% Rhizoma Atractylodis Macrocephalae, 6% Poria, the 4.5%th full building, 5.4% Bulbus Allii Macrostemonis, 6% Fructus Lycii, 4% Radix Glycyrrhizae, 3% Herba Menthae, 5% Fructus Gardeniae, 5.5% Herba Artemisiae Scopariae, 5.5% Cymbidium ensifolium (L.) Sw. root, 4% Radix Scutellariae, 7% Radix Sophorae Flavescentis, 5% Radix Rehmanniae, 3% Fructus Aurantii, 6% Fructus Crataegi, 4% Semen Raphani (the above-mentioned unit of weight that is) mix homogeneously, make main body with conventional method and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
C, the Radix Notoginseng with 55%, 2% Dan Xiang, 2% SHANGMEIQI, 0.8% Oleum menthae, 10.2% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration and are in 95% the ethanol, and obtaining concentration is the 50%(weight/volume) reinforcement solution;
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, with the 95%(volume) main body decoct juice, 1%(volume) broken flavor fourth liquid, 2%(volume) reinforcement loose solution and 2%(volume) Herba Pogostemonis decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
Embodiment 2:
The Bao oral liquid of this hepatitis B is made by following method:
A, with 20 gram CAIHU, 25 gram Rhizoma Cyperis, 23 gram radix curcumaes, 22 gram Radix Angelicae Sinensis, the 20 gram Radix Paeoniae Albas, the 30 gram Rhizoma Atractylodis Macrocephalaes, 25 gram Poria, 25 gram Jin Lou, 22.5 gram Bulbus Allii Macrostemonis, 32.5% Fructus Lyciis, 25 gram Radix Glycyrrhizaes, 10 gram Herba Menthaes, 30 Keshan Cape jasmines, 22.5 gram Herba Artemisiae Scopariaes, 22.5 gram Radix Isatidiss, 30 gram Radix Scutellariaes, 25 gram Radix Sophorae Flavescentiss, the 30 gram Radix Rehmanniae, 20 gram Fructus Aurantiis, 25 Keshan short, bristly hair or beards, 15 gram Semen Raphani mix homogeneously, decoct with conventional method and to obtain main body and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
C, with 58 gram Radix Notoginsengs, 28 Ke Dan townshiies, 3 gram SHANGMEIQIs, 1 gram Oleum menthae, 10 gram Rhizoma Acori Graminei mix homogeneously, be immersed in concentration and be in 95% the ethanol, obtain 200 milliliters the reinforcement solution that looses;
D, 100 gram Herba Pogostemoniss are decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, 92 milliliters of main bodys are decocted juice, 2 milliliters of broken flavor fourth liquid, 4 milliliters strengthen loosing solution and 4 milliliters of Herba Pogostemoniss decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain the Bao oral liquid of 100 milliliters of hepatitis B.
Clinical example 1:
Patient: the technique center Wang Li of Shiyan City, Hubei Province No. 2 Automobile Factory, do liver function test and find that GPT increases, surface antigen belongs to positive, be diagnosed as hepatitis B, do not see obvious improvement, after take the Bao oral liquid of trimestral hepatitis B of the present invention through hospitalize, the every index of liver function test is normal, appetite increases, and has rosy cheeks, and all malaise symptoms are thoroughly eliminated.
Clinical example 2:
Patient: the Wu Qiuping of production scheduling place of Shiyan City, Hubei Province No. 2 Automobile Factory, suffer from the serious symptom hepatitis B did not heal in hospital in four months, no appetite, malaise is after take the Bao oral liquid of trimestral hepatitis B of the present invention, liver function check and ultrasound diagnosis index are normal, special examination two double full feminine genders that belong to, physical recovery has been married as before, given birth to child, always operate as normal and life.

Claims (1)

1, manufacture method of a kind of hepatitis B oral liquid and products thereof is characterized in that:
A, with 2~4% CAIHU, 3~5% radix curcumaes, 4~6% Radix Angelicae Sinensis, 4~6% Radix Paeoniae Albas, 4~6% Rhizoma Atractylodis Macrocephalaes, 4~6% Poria, the 4th~6% full buildings, 4~6% Bulbus Allii Macrostemonis, 5~7% Fructus Lyciis, 3~5% Radix Glycyrrhizaes, 1~3% Herba Menthae, 4~7% Fructus Gardeniae, 4~6% Herba Artemisiae Scopariaes, 4~6% Radix Isatidiss, 4~6% Radix Scutellariaes, 5~7% Radix Sophorae Flavescentiss, 5~7% Radix Rehmanniae, 2~4% Fructus Aurantiis, 4~6% Fructus Crataegis, 2~4% Semen Raphanis (the above-mentioned unit of weight that is) mix homogeneously, make main body according to a conventional method and decoct juice
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid,
It is in 95% the ethanol that c, the Radix Notoginseng with 50~60%, 25~35% Dan Xiang, 1~3% SHANGMEIQI, 0.5~1.5% Oleum menthae, 8~12% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration, obtaining concentration is the diffusing solution of reinforcement of 45~55% (weight/volume)
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice,
The loose Herba Pogostemonis of solution and 2~4% (volume) of e, the reinforcement that the main body of 92~95% (volumes) is decocted broken flavor fourth liquid, 2~4% (volumes) of juice, 1~2% (volume) decocts the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
CN 94109284 1994-08-29 1994-08-29 Oral liquid for curing hepatitis B, and method for prodn. of same Pending CN1112834A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 94109284 CN1112834A (en) 1994-08-29 1994-08-29 Oral liquid for curing hepatitis B, and method for prodn. of same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 94109284 CN1112834A (en) 1994-08-29 1994-08-29 Oral liquid for curing hepatitis B, and method for prodn. of same

Publications (1)

Publication Number Publication Date
CN1112834A true CN1112834A (en) 1995-12-06

Family

ID=5033848

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 94109284 Pending CN1112834A (en) 1994-08-29 1994-08-29 Oral liquid for curing hepatitis B, and method for prodn. of same

Country Status (1)

Country Link
CN (1) CN1112834A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054540C (en) * 1998-01-12 2000-07-19 李铁敏 Anti-hepatitis B virus preparation of traditional Chinese medicine and its preparing method
CN1061554C (en) * 1998-11-19 2001-02-07 潘建新 Chinese patent drug for curing hepatitis B
CN1061869C (en) * 1996-09-10 2001-02-14 吴荫福 Recovering powder for hepatitis B
CN1098089C (en) * 1998-04-28 2003-01-08 天津市新迪亚医药新技术发展有限公司 Medicine for treating hepatitis and liver fibrosis, and method for preparing same
CN100382824C (en) * 2006-04-24 2008-04-23 辽宁本溪三药有限公司 Chinese traditional medicine for treating chronic hepatitis, and preparation method
US8080264B2 (en) * 2004-11-24 2011-12-20 Himalaya Global Holdings Ltd. Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
CN107362329A (en) * 2017-07-20 2017-11-21 闫鹏生 A kind of Chinese medicine treated hepatitis B great three positive and turned out cloudy

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1061869C (en) * 1996-09-10 2001-02-14 吴荫福 Recovering powder for hepatitis B
CN1054540C (en) * 1998-01-12 2000-07-19 李铁敏 Anti-hepatitis B virus preparation of traditional Chinese medicine and its preparing method
CN1098089C (en) * 1998-04-28 2003-01-08 天津市新迪亚医药新技术发展有限公司 Medicine for treating hepatitis and liver fibrosis, and method for preparing same
CN1061554C (en) * 1998-11-19 2001-02-07 潘建新 Chinese patent drug for curing hepatitis B
US8080264B2 (en) * 2004-11-24 2011-12-20 Himalaya Global Holdings Ltd. Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
CN100382824C (en) * 2006-04-24 2008-04-23 辽宁本溪三药有限公司 Chinese traditional medicine for treating chronic hepatitis, and preparation method
CN107362329A (en) * 2017-07-20 2017-11-21 闫鹏生 A kind of Chinese medicine treated hepatitis B great three positive and turned out cloudy

Similar Documents

Publication Publication Date Title
CN1186043C (en) Exterior-applied medicine for treating osteopathy
CN1305844A (en) Medicine for treating congestive heart failure
CN101190323A (en) Orally-taken traditional Chinese medicine soup acquired immuno-deficiency syndrome
CN1193775C (en) Rheumatoid disease treating capsule
CN1112834A (en) Oral liquid for curing hepatitis B, and method for prodn. of same
CN1994453B (en) Orally administered Chinese medicine for treating dysmenorrheal caused by qi stagnation and blood stasis
CN1111522A (en) Compound islets Langerhans regenerated capsule
CN1657067A (en) Chinese medicine for treating psoriasis
CN1120943A (en) Nose opening capsule and its preparation method
CN1036699A (en) " skin medicine " liquid medicine compound method
CN1365819A (en) Medicine for treating apoplexy
CN1331996A (en) Hepatitis B treaitng pill
CN1180821C (en) Medicine for treating cerebral thrombus and its prepn
CN1067571C (en) Chinese medicine capsule for treating lumbar and cervical protrusion
CN1087821A (en) A kind of medicament and preparation method of removing acne
CN1084630C (en) Mastopathy treating ointment
CN1255149C (en) Combination of medication
CN1054767C (en) Pharmaceutical preparation for treatment of leukoderma
CN1322558A (en) Liver cancer resisting medicine
CN1565544A (en) Medicine for treating cold disease
CN1035954A (en) Fluid for seasonal illness
CN1117856A (en) Medicine for radically curing constipation
CN1077797C (en) Chinese medicine powder preparation for curing leukemia
CN1129578A (en) Formulation of Ganmaosuyusan for curing common cold
CN1061554C (en) Chinese patent drug for curing hepatitis B

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication